0102030405
CAS No 302962-49-8DASATINIB ANHYDROUS Pharmaceutical Intermediates
02
Product detail
Product detail
Anhydrous dasatinib is a potent tyrosine kinase inhibitor that plays a vital role in the treatment of certain types of cancer. Its chemical formula isC22H26ClN7O2S and its molecular weight is 488.01 g/mol. The product is a white to off-white crystalline powder that is highly soluble in organic solvents such as dimethyl sulfoxide (DMSO) and methanol, but has limited solubility in water.
The anhydrous form of dasatinib is particularly advantageous because it eliminates water molecules that could affect the compound's stability and efficacy. This property ensures that the product maintains its potency over a long period of time, making it a reliable choice for pharmaceutical formulations. The melting point of anhydrous dasatinib is approximately 200-205°C, which helps it maintain stability under a variety of storage conditions.
02
product detail
|
CAS No. |
40856-44-8 |
|
EINECS |
609-874-3 |
|
Formula |
C9H11NO2 |
|
Molecular Weight |
165.19 |
|
Appearance |
White to Off-White solid |
|
Purity |
≥98% |
|
Type |
Pharmaceutical Intermediates |
Anhydrous dasatinib has several advantages that make it the preferred choice in the pharmaceutical industry:
1. Enhanced stability: Compared to the hydrated form, the anhydrous form has better stability, reducing the risk of degradation and ensuring a longer shelf life.
2. High Bioavailability: Anhydrous dasatinib is designed to achieve high bioavailability, allowing for effective absorption and utilization by the body, which is critical for therapeutic efficacy.
3. Targeted effect: As a selective inhibitor of multiple tyrosine kinases, dasatinib anhydrate can effectively target cancer cells while minimizing the impact on normal cells, resulting in better patient treatment outcomes.
4. Multiple formulation options: The product can be easily incorporated into a variety of drug formulations, including tablets, capsules, and injections, providing flexibility to manufacturers.
5. Regulatory Compliance: Our manufacturing processes adhere to Good Manufacturing Practice (GMP) and other regulatory standards to ensure that anhydrous dasatinib is safe and effective for pharmaceutical applications.
Dasatinib anhydrous is primarily used in the pharmaceutical industry to treat hematological malignancies, particularly chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). Its ability to inhibit specific tyrosine kinases involved in cancer cell proliferation makes it a key ingredient in targeted cancer therapy.
In addition to its use in cancer treatment, dasatinib anhydrous is also being explored for other therapeutic areas, including autoimmune diseases and other malignancies. Ongoing research and development in this area highlights the versatility of this compound and its potential for broader applications.
As a factory integrating production and trading, we prioritize quality at every stage of our operations. Our state-of-the-art manufacturing facilities are equipped with advanced technologies and adhere to strict quality control measures. We source raw materials from reputable suppliers and perform rigorous testing to ensure that anhydrous dasatinib meets the highest standards of purity and efficacy.
Our dedicated team is committed to providing exceptional customer service, ensuring our customers receive the support they need throughout the purchasing process. We understand the importance of timely delivery and work hard to meet our customers' needs efficiently.
In summary, anhydrous dasatinib is a high-quality pharmaceutical product that offers numerous advantages for cancer treatment and other therapeutic applications. With our commitment to quality and customer satisfaction, we are your trusted partner in the pharmaceutical industry. Choose anhydrous dasatinib for reliable performance and superior results.